Adjuvant molecularly targeted therapy—epidermal growth factor tyrosine kinase inhibition and beyond

Benzer Materyaller

• Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
  Yazar:: Tabbò, Fabrizio, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Nitric oxide reversibly inhibits the epidermal growth factor receptor tyrosine kinase.
  Yazar:: Estrada, C, ve diğerleri
  Baskı/Yayın Bilgisi: (1997)
• Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
  Yazar:: Zhai, Haoran, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease?
  Yazar:: Kim, Young Hak, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase Ameliorates Collagen-Induced Arthritis
  Yazar:: Swanson, Christina D., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)